Skip to main content
Hikal Ltd. logo

Hikal Ltd. — Investor Relations & Filings

Ticker · HIKAL ISIN · INE475B01022 LEI · 335800OLTGHHYZWTF859 BSE.NS Manufacturing
Filings indexed 737 across all filing types
Latest filing 2020-08-21 AGM Information
Country IN India
Listing BSE.NS HIKAL

About Hikal Ltd.

https://www.hikal.com

Hikal Ltd. provides solutions across the life sciences value chain, specializing in the development and manufacturing of active ingredients, intermediates, and formulations. The company operates through two primary business segments: Pharmaceuticals and Crop Protection. In the pharmaceutical division, it focuses on the production of Active Pharmaceutical Ingredients (APIs) and advanced intermediates for various therapeutic areas. The crop protection segment involves the contract manufacturing of pesticides, herbicides, and fungicides for global agrochemical leaders. Hikal offers comprehensive Contract Research and Manufacturing Services (CRAMS), leveraging its research and development capabilities to support clients from early-stage development to commercial-scale production. Its facilities adhere to international quality standards, maintaining a strong track record of regulatory compliance with global health authorities.

Recent filings

Filing Released Lang Actions
Shareholders meeting
AGM Information Classification · 100% confidence The document is a Notice calling the 32nd Annual General Meeting (AGM) of Hikal Ltd. It includes details about the date, time, and mode of the AGM, the agenda items to be discussed including adoption of financial statements, dividend declaration, director appointments, and auditor remuneration. It also contains procedural notes about e-voting, attendance, and regulatory compliance related to the AGM. The document is not the Annual Report itself but the official notice for the AGM meeting where such reports will be considered. The length is about 15,000 characters, which is consistent with a detailed AGM notice including explanatory notes. Therefore, this document fits the category of AGM Information (AGM-R).
2020-08-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2020-08-11 English
Change in Company Secretary/Compliance Officer
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding a change in the company's Company Secretary and Compliance Officer. It mentions the cessation of Mr. Sham Wahalekar and the appointment of Mr. Rajasekhar Reddy effective from 5th August 2020. The content focuses solely on management personnel changes without any financial data, report attachments, or regulatory certifications. This fits the category of announcements about changes in senior management or board members. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is short and does not contain financial statements or report details, so it is not an annual report or regulatory filing. Confidence is high due to clear and explicit content about management change.
2020-08-04 English
Press Release
Regulatory Filings
2020-08-04 English
Financial Result Updates
Regulatory Filings
2020-08-04 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Hikal Ltd. dated July 28, 2020, addressed to stock exchanges (BSE and NSE) regarding the correction of the trading window reopening date. It mentions the upcoming Board meeting for approval of unaudited financial results for the quarter ended June 30, 2020, scheduled on August 4, 2020, and revises the trading window reopening date to August 7, 2020. The document is short (1618 characters) and serves as a notification about trading window dates related to insider trading restrictions around financial results announcements. It does not contain any financial data, report, or detailed analysis. It is not an earnings release or interim report itself but a regulatory communication about trading restrictions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.